cloudfront

Report Detail



Pharma & HealthcareGlobal Drugs for Dermatophytosis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541471
  • |
  • 5 November, 2018
  • |
  • Global
  • |
  • 124 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Drugs for Dermatophytosis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Drugs for Dermatophytosis Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Rx
  • 1.2.2 OTC
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Novartis
    • 2.1.1 Business Overview
  • 2.1.2 Drugs for Dermatophytosis Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Novartis Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Drugs for Dermatophytosis Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Sanofi-Aventis
  • 2.3.1 Business Overview
  • 2.3.2 Drugs for Dermatophytosis Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Sanofi-Aventis Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Merck
  • 2.4.1 Business Overview
  • 2.4.2 Drugs for Dermatophytosis Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Merck Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Enzon Pharmaceuticals
  • 2.5.1 Business Overview
  • 2.5.2 Drugs for Dermatophytosis Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Enzon Pharmaceuticals Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Bayer
  • 2.6.1 Business Overview
  • 2.6.2 Drugs for Dermatophytosis Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Bayer Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Astellas Pharma
  • 2.7.1 Business Overview
  • 2.7.2 Drugs for Dermatophytosis Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Astellas Pharma Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 GSK
  • 2.8.1 Business Overview
  • 2.8.2 Drugs for Dermatophytosis Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 GSK Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Abbott
  • 2.9.1 Business Overview
  • 2.9.2 Drugs for Dermatophytosis Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Abbott Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Drugs for Dermatophytosis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Drugs for Dermatophytosis Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Drugs for Dermatophytosis Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Drugs for Dermatophytosis Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Drugs for Dermatophytosis Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Drugs for Dermatophytosis Market Analysis by Regions

    • 4.1 Global Drugs for Dermatophytosis Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Drugs for Dermatophytosis Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Drugs for Dermatophytosis Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 4.3 Europe Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 4.5 South America Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 5 North America Drugs for Dermatophytosis by Countries

    • 5.1 North America Drugs for Dermatophytosis Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Drugs for Dermatophytosis Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Drugs for Dermatophytosis Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 5.3 Canada Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 6 Europe Drugs for Dermatophytosis by Countries

    • 6.1 Europe Drugs for Dermatophytosis Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Drugs for Dermatophytosis Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Drugs for Dermatophytosis Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 6.3 UK Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 6.4 France Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 6.5 Russia Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 6.6 Italy Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Drugs for Dermatophytosis by Countries

    • 7.1 Asia-Pacific Drugs for Dermatophytosis Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Drugs for Dermatophytosis Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Drugs for Dermatophytosis Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 7.3 Japan Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 7.4 Korea Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 7.5 India Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 8 South America Drugs for Dermatophytosis by Countries

    • 8.1 South America Drugs for Dermatophytosis Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Drugs for Dermatophytosis Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Drugs for Dermatophytosis Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Drugs for Dermatophytosis by Countries

    • 9.1 Middle East and Africa Drugs for Dermatophytosis Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Drugs for Dermatophytosis Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Drugs for Dermatophytosis Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 9.3 UAE Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Drugs for Dermatophytosis Sales and Growth Rate (2013-2018)
  • 10 Global Drugs for Dermatophytosis Market Segment by Type

    • 10.1 Global Drugs for Dermatophytosis Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Drugs for Dermatophytosis Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Drugs for Dermatophytosis Revenue and Market Share by Type (2013-2018)
  • 10.2 Rx Sales Growth and Price
  • 10.2.1 Global Rx Sales Growth (2013-2018)
  • 10.2.2 Global Rx Price (2013-2018)
  • 10.3 OTC Sales Growth and Price
  • 10.3.1 Global OTC Sales Growth (2013-2018)
  • 10.3.2 Global OTC Price (2013-2018)
  • 11 Global Drugs for Dermatophytosis Market Segment by Application

    • 11.1 Global Drugs for Dermatophytosis Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Clinic Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Drugs for Dermatophytosis Market Forecast (2018-2023)

    • 12.1 Global Drugs for Dermatophytosis Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Drugs for Dermatophytosis Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Drugs for Dermatophytosis Market Forecast (2018-2023)
  • 12.2.2 Europe Drugs for Dermatophytosis Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Drugs for Dermatophytosis Market Forecast (2018-2023)
  • 12.2.4 South America Drugs for Dermatophytosis Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Drugs for Dermatophytosis Market Forecast (2018-2023)
  • 12.3 Drugs for Dermatophytosis Market Forecast by Type (2018-2023)
  • 12.3.1 Global Drugs for Dermatophytosis Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Drugs for Dermatophytosis Market Share Forecast by Type (2018-2023)
  • 12.4 Drugs for Dermatophytosis Market Forecast by Application (2018-2023)
  • 12.4.1 Global Drugs for Dermatophytosis Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Drugs for Dermatophytosis Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.

      Scope of the Report:

      The worldwide market for Drugs for Dermatophytosis is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Drugs for Dermatophytosis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Novartis

      Pfizer

      Sanofi-Aventis

      Merck

      Enzon Pharmaceuticals

      Bayer

      Astellas Pharma

      GSK

      Abbott

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Rx

      OTC

      Market Segment by Applications, can be divided into

      Hospital

      Clinic

      Other

      There are 15 Chapters to deeply display the global Drugs for Dermatophytosis market.

      Chapter 1, to describe Drugs for Dermatophytosis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Drugs for Dermatophytosis, with sales, revenue, and price of Drugs for Dermatophytosis, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Dermatophytosis, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Drugs for Dermatophytosis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Drugs for Dermatophytosis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Drugs for Dermatophytosis . Industry analysis & Market Report on Drugs for Dermatophytosis is a syndicated market report, published as Global Drugs for Dermatophytosis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Drugs for Dermatophytosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Add To Cart Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report